CN Stock MarketDetailed Quotes

002099 Zhejiang Hisoar Pharmaceutical

Watchlist
  • 5.94
  • -0.03-0.50%
Not Open Oct 21 15:00 CST
9.62BMarket Cap-23951P/E (TTM)

Zhejiang Hisoar Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-13.17%1.04B
-16.65%528.46M
-19.68%2.17B
-19.05%1.68B
-18.49%1.2B
-21.19%634.05M
8.83%2.7B
15.63%2.07B
23.46%1.47B
25.26%804.53M
Operating revenue
-13.17%1.04B
-16.65%528.46M
-19.68%2.17B
-19.05%1.68B
-18.49%1.2B
-21.19%634.05M
8.83%2.7B
15.63%2.07B
23.46%1.47B
25.26%804.53M
Other operating revenue
40.48%11.49M
----
43.04%9.14M
----
400.64%8.18M
----
-20.00%6.39M
----
-61.07%1.63M
----
Total operating cost
-15.07%962.35M
-29.52%452.55M
-5.77%2.33B
-7.61%1.66B
-10.89%1.13B
-9.30%642.13M
4.62%2.48B
4.42%1.8B
12.39%1.27B
25.90%708M
Operating cost
-21.75%746.61M
-28.59%362.06M
-5.88%1.87B
-7.55%1.35B
-6.35%954.19M
-9.99%507.04M
27.22%1.98B
30.99%1.46B
40.12%1.02B
48.93%563.34M
Operating tax surcharges
-6.08%12.76M
3.37%6.27M
30.47%27.76M
32.83%20.46M
28.97%13.59M
3.43%6.06M
-20.42%21.28M
-20.55%15.4M
-23.49%10.53M
-7.52%5.86M
Operating expense
4.43%14.07M
10.46%5.27M
11.18%29.22M
19.54%20.98M
20.21%13.47M
-11.57%4.77M
-1.64%26.28M
-5.77%17.55M
15.41%11.2M
33.04%5.4M
Administration expense
-0.47%144.13M
-8.14%62.69M
-19.27%324.87M
-31.65%227.19M
-33.38%144.81M
-28.00%68.24M
-29.31%402.44M
-24.12%332.41M
-25.00%217.37M
-34.33%94.78M
Financial expense
65.34%-19.44M
-155.09%-13.75M
69.44%-31.32M
61.24%-54.75M
4.34%-56.08M
547.97%24.96M
-607.29%-102.48M
-7,230.61%-141.25M
-783.86%-58.62M
135.54%3.85M
-Interest expense (Financial expense)
4.99%18.71M
88.17%11.17M
3.33%37.76M
10.81%26.95M
2.20%17.82M
22.47%5.94M
66.99%36.55M
90.09%24.32M
59.98%17.44M
35.16%4.85M
-Interest Income (Financial expense)
38.60%-25.55M
-105.94%-19.66M
-103.54%-68.13M
-195.84%-57.88M
-161.12%-41.61M
-141.26%-9.54M
-1.42%-33.47M
15.73%-19.57M
0.45%-15.94M
39.30%-3.96M
Research and development
1.80%64.22M
-3.32%30.01M
-20.25%115.56M
-14.55%93.28M
-12.49%63.09M
-10.70%31.04M
-11.98%144.91M
-12.84%109.16M
-12.38%72.09M
-13.52%34.76M
Credit Impairment Loss
-120.22%-2.57M
-96.35%407.05K
176.54%13.41M
958.83%20.13M
333.38%12.73M
371.20%11.16M
-73.78%-17.53M
31.84%-2.34M
22.34%-5.46M
49.48%-4.11M
Asset Impairment Loss
---49.77M
---47.65M
-183.95%-237.86M
----
----
----
-676.32%-83.77M
----
----
----
Other net revenue
9.22%-41.28M
-189.56%-46.91M
-155.65%-302.79M
-57.14%-61.87M
-4,707.11%-45.48M
1,331.18%52.38M
-2,925.45%-118.44M
-270.18%-39.37M
-93.26%987.07K
141.27%3.66M
Fair value change income
110.54%6.76M
----
-432.34%-104.25M
9.15%-43.8M
-1,365.09%-64.16M
687.33%9.26M
-402.93%-19.58M
-464.86%-48.21M
-132.01%-4.38M
---1.58M
Invest income
42.43%-7.06M
-129.99%-6.03M
41.24%-13.37M
-1,670.11%-61.42M
-800.04%-12.26M
244.93%20.09M
-781.98%-22.75M
-200.16%-3.47M
555.93%1.75M
401.24%5.82M
-Including: Investment income associates
42.47%-5.14M
-27.25%-3.87M
48.91%-16.84M
10.99%-8.77M
-30.22%-8.93M
-0.47%-3.04M
-286.34%-32.97M
-254.05%-9.85M
-189.24%-6.86M
-56.74%-3.03M
Asset deal income
-96.53%365.09K
-97.21%231.69K
4,326.85%12.88M
1,926.27%9.84M
2,950.15%10.53M
5,023.79%8.3M
119.64%290.87K
1.68%485.41K
-27.67%345.32K
518.17%162.04K
Other revenue
43.20%10.99M
71.87%6.13M
6.06%26.41M
-5.54%13.38M
-12.01%7.68M
5.91%3.56M
48.68%24.9M
40.30%14.16M
33.27%8.73M
56.45%3.37M
Operating profit
96.70%35.21M
-34.52%29.01M
-524.36%-464.24M
-118.80%-44.36M
-90.93%17.9M
-55.78%44.3M
-10.36%109.4M
149.57%236.01M
173.18%197.33M
40.93%100.19M
Add:Non operating Income
2,933.32%1.58M
6,373.93%1.02M
-84.09%243.96K
-96.48%33.4K
-94.95%52.14K
-97.98%15.7K
-37.86%1.53M
-70.79%948.19K
-54.66%1.03M
1,031.02%777.87K
Less:Non operating expense
-68.19%287.25K
-19.98%196.06K
-78.04%2.22M
32.87%1.4M
1,322.93%902.99K
96.56%245.03K
585.03%10.13M
-58.51%1.06M
-96.21%63.46K
-81.14%124.66K
Total profit
114.11%36.5M
-32.32%29.83M
-562.51%-466.22M
-119.38%-45.73M
-91.40%17.05M
-56.30%44.07M
-18.07%100.8M
147.63%235.9M
172.26%198.3M
43.04%100.84M
Less:Income tax cost
84.27%-218.95K
-202.14%-2.27M
-403.17%-44.64M
-120.84%-6.25M
-105.06%-1.39M
-84.46%2.22M
-49.51%14.73M
51.66%29.98M
110.32%27.5M
4.71%14.29M
Net profit
99.14%36.72M
-23.30%32.1M
SL-421.58M
SL-39.48M
-89.20%18.44M
-51.65%41.85M
-8.30%86.08M
172.76%205.92M
185.81%170.8M
52.25%86.55M
Net profit from continuing operation
99.14%36.72M
-23.30%32.1M
-589.77%-421.58M
-119.17%-39.48M
-89.20%18.44M
-51.65%41.85M
-8.30%86.08M
172.76%205.92M
185.81%170.8M
52.25%86.55M
Less:Minority Profit
-88.73%-1.38M
-95.86%-495.53K
21.20%-1.53M
25.34%-891.29K
14.95%-733.19K
46.90%-253K
-42.12%-1.94M
-2.48%-1.19M
-15.35%-862.11K
-39.40%-476.46K
Net profit of parent company owners
98.74%38.1M
-22.58%32.59M
-577.26%-420.06M
-118.63%-38.59M
-88.83%19.17M
-51.62%42.1M
-7.58%88.01M
170.17%207.12M
183.71%171.66M
52.17%87.02M
Earning per share
Basic earning per share
100.00%0.02
0.00%0.02
-620.00%-0.26
-115.38%-0.02
-90.91%0.01
-60.00%0.02
-16.67%0.05
160.00%0.13
175.00%0.11
25.00%0.05
Diluted earning per share
100.00%0.02
0.00%0.02
-620.00%-0.26
-115.38%-0.02
-90.91%0.01
-60.00%0.02
-16.67%0.05
160.00%0.13
175.00%0.11
25.00%0.05
Other composite income
-115.03%-634.72K
1,513.22%4.22M
36.40%-293.47K
Other composite income of parent company owners
----
----
-115.03%-634.72K
----
----
----
1,513.22%4.22M
36.40%-293.47K
----
----
Total composite income
99.14%36.72M
-23.30%32.1M
-567.56%-422.22M
-119.20%-39.48M
-89.20%18.44M
-51.65%41.85M
-3.49%90.3M
174.04%205.63M
185.09%170.8M
51.86%86.55M
Total composite income of parent company owners
98.74%38.1M
-22.58%32.59M
-556.10%-420.69M
-118.66%-38.59M
-88.83%19.17M
-51.62%42.1M
-2.84%92.24M
171.42%206.82M
183.00%171.66M
51.79%87.02M
Total composite income of minority owners
-88.73%-1.38M
-95.86%-495.53K
21.20%-1.53M
25.34%-891.29K
14.95%-733.19K
46.90%-253K
-42.12%-1.94M
-2.48%-1.19M
-15.35%-862.11K
-39.40%-476.46K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -13.17%1.04B-16.65%528.46M-19.68%2.17B-19.05%1.68B-18.49%1.2B-21.19%634.05M8.83%2.7B15.63%2.07B23.46%1.47B25.26%804.53M
Operating revenue -13.17%1.04B-16.65%528.46M-19.68%2.17B-19.05%1.68B-18.49%1.2B-21.19%634.05M8.83%2.7B15.63%2.07B23.46%1.47B25.26%804.53M
Other operating revenue 40.48%11.49M----43.04%9.14M----400.64%8.18M-----20.00%6.39M-----61.07%1.63M----
Total operating cost -15.07%962.35M-29.52%452.55M-5.77%2.33B-7.61%1.66B-10.89%1.13B-9.30%642.13M4.62%2.48B4.42%1.8B12.39%1.27B25.90%708M
Operating cost -21.75%746.61M-28.59%362.06M-5.88%1.87B-7.55%1.35B-6.35%954.19M-9.99%507.04M27.22%1.98B30.99%1.46B40.12%1.02B48.93%563.34M
Operating tax surcharges -6.08%12.76M3.37%6.27M30.47%27.76M32.83%20.46M28.97%13.59M3.43%6.06M-20.42%21.28M-20.55%15.4M-23.49%10.53M-7.52%5.86M
Operating expense 4.43%14.07M10.46%5.27M11.18%29.22M19.54%20.98M20.21%13.47M-11.57%4.77M-1.64%26.28M-5.77%17.55M15.41%11.2M33.04%5.4M
Administration expense -0.47%144.13M-8.14%62.69M-19.27%324.87M-31.65%227.19M-33.38%144.81M-28.00%68.24M-29.31%402.44M-24.12%332.41M-25.00%217.37M-34.33%94.78M
Financial expense 65.34%-19.44M-155.09%-13.75M69.44%-31.32M61.24%-54.75M4.34%-56.08M547.97%24.96M-607.29%-102.48M-7,230.61%-141.25M-783.86%-58.62M135.54%3.85M
-Interest expense (Financial expense) 4.99%18.71M88.17%11.17M3.33%37.76M10.81%26.95M2.20%17.82M22.47%5.94M66.99%36.55M90.09%24.32M59.98%17.44M35.16%4.85M
-Interest Income (Financial expense) 38.60%-25.55M-105.94%-19.66M-103.54%-68.13M-195.84%-57.88M-161.12%-41.61M-141.26%-9.54M-1.42%-33.47M15.73%-19.57M0.45%-15.94M39.30%-3.96M
Research and development 1.80%64.22M-3.32%30.01M-20.25%115.56M-14.55%93.28M-12.49%63.09M-10.70%31.04M-11.98%144.91M-12.84%109.16M-12.38%72.09M-13.52%34.76M
Credit Impairment Loss -120.22%-2.57M-96.35%407.05K176.54%13.41M958.83%20.13M333.38%12.73M371.20%11.16M-73.78%-17.53M31.84%-2.34M22.34%-5.46M49.48%-4.11M
Asset Impairment Loss ---49.77M---47.65M-183.95%-237.86M-------------676.32%-83.77M------------
Other net revenue 9.22%-41.28M-189.56%-46.91M-155.65%-302.79M-57.14%-61.87M-4,707.11%-45.48M1,331.18%52.38M-2,925.45%-118.44M-270.18%-39.37M-93.26%987.07K141.27%3.66M
Fair value change income 110.54%6.76M-----432.34%-104.25M9.15%-43.8M-1,365.09%-64.16M687.33%9.26M-402.93%-19.58M-464.86%-48.21M-132.01%-4.38M---1.58M
Invest income 42.43%-7.06M-129.99%-6.03M41.24%-13.37M-1,670.11%-61.42M-800.04%-12.26M244.93%20.09M-781.98%-22.75M-200.16%-3.47M555.93%1.75M401.24%5.82M
-Including: Investment income associates 42.47%-5.14M-27.25%-3.87M48.91%-16.84M10.99%-8.77M-30.22%-8.93M-0.47%-3.04M-286.34%-32.97M-254.05%-9.85M-189.24%-6.86M-56.74%-3.03M
Asset deal income -96.53%365.09K-97.21%231.69K4,326.85%12.88M1,926.27%9.84M2,950.15%10.53M5,023.79%8.3M119.64%290.87K1.68%485.41K-27.67%345.32K518.17%162.04K
Other revenue 43.20%10.99M71.87%6.13M6.06%26.41M-5.54%13.38M-12.01%7.68M5.91%3.56M48.68%24.9M40.30%14.16M33.27%8.73M56.45%3.37M
Operating profit 96.70%35.21M-34.52%29.01M-524.36%-464.24M-118.80%-44.36M-90.93%17.9M-55.78%44.3M-10.36%109.4M149.57%236.01M173.18%197.33M40.93%100.19M
Add:Non operating Income 2,933.32%1.58M6,373.93%1.02M-84.09%243.96K-96.48%33.4K-94.95%52.14K-97.98%15.7K-37.86%1.53M-70.79%948.19K-54.66%1.03M1,031.02%777.87K
Less:Non operating expense -68.19%287.25K-19.98%196.06K-78.04%2.22M32.87%1.4M1,322.93%902.99K96.56%245.03K585.03%10.13M-58.51%1.06M-96.21%63.46K-81.14%124.66K
Total profit 114.11%36.5M-32.32%29.83M-562.51%-466.22M-119.38%-45.73M-91.40%17.05M-56.30%44.07M-18.07%100.8M147.63%235.9M172.26%198.3M43.04%100.84M
Less:Income tax cost 84.27%-218.95K-202.14%-2.27M-403.17%-44.64M-120.84%-6.25M-105.06%-1.39M-84.46%2.22M-49.51%14.73M51.66%29.98M110.32%27.5M4.71%14.29M
Net profit 99.14%36.72M-23.30%32.1MSL-421.58MSL-39.48M-89.20%18.44M-51.65%41.85M-8.30%86.08M172.76%205.92M185.81%170.8M52.25%86.55M
Net profit from continuing operation 99.14%36.72M-23.30%32.1M-589.77%-421.58M-119.17%-39.48M-89.20%18.44M-51.65%41.85M-8.30%86.08M172.76%205.92M185.81%170.8M52.25%86.55M
Less:Minority Profit -88.73%-1.38M-95.86%-495.53K21.20%-1.53M25.34%-891.29K14.95%-733.19K46.90%-253K-42.12%-1.94M-2.48%-1.19M-15.35%-862.11K-39.40%-476.46K
Net profit of parent company owners 98.74%38.1M-22.58%32.59M-577.26%-420.06M-118.63%-38.59M-88.83%19.17M-51.62%42.1M-7.58%88.01M170.17%207.12M183.71%171.66M52.17%87.02M
Earning per share
Basic earning per share 100.00%0.020.00%0.02-620.00%-0.26-115.38%-0.02-90.91%0.01-60.00%0.02-16.67%0.05160.00%0.13175.00%0.1125.00%0.05
Diluted earning per share 100.00%0.020.00%0.02-620.00%-0.26-115.38%-0.02-90.91%0.01-60.00%0.02-16.67%0.05160.00%0.13175.00%0.1125.00%0.05
Other composite income -115.03%-634.72K1,513.22%4.22M36.40%-293.47K
Other composite income of parent company owners ---------115.03%-634.72K------------1,513.22%4.22M36.40%-293.47K--------
Total composite income 99.14%36.72M-23.30%32.1M-567.56%-422.22M-119.20%-39.48M-89.20%18.44M-51.65%41.85M-3.49%90.3M174.04%205.63M185.09%170.8M51.86%86.55M
Total composite income of parent company owners 98.74%38.1M-22.58%32.59M-556.10%-420.69M-118.66%-38.59M-88.83%19.17M-51.62%42.1M-2.84%92.24M171.42%206.82M183.00%171.66M51.79%87.02M
Total composite income of minority owners -88.73%-1.38M-95.86%-495.53K21.20%-1.53M25.34%-891.29K14.95%-733.19K46.90%-253K-42.12%-1.94M-2.48%-1.19M-15.35%-862.11K-39.40%-476.46K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data